Madam President, when 67-year-old Pamela Gunter started treatment for breast cancer, her doctor knew it would be a grueling fight. He also knew it was a fight she could win. Pamela's doctor put her on Taxol, a common chemotherapy drug. The results were excellent. Her tumor shrank. Her prognosis was good. Then one day last spring, no more Taxol. The doctor could not get it. It is one of the most popular and effective treatments for breast, lung, and ovarian cancer, and it suddenly disappeared from the markets in Nevada. Doctors couldn't get it; drug suppliers could not say why. So Pamela's doctor was forced to use a much more expensive and much less effective course of treatment. The cancer spread. By the time Taxol was available again, Pamela was dead. She left behind a loving husband, two grown sons, and a grandchild. But with the right treatment she would still be alive today. Her Las Vegas doctor said a shortage of this common generic medicine directly contributed to her death. Had this product been available, she would have been fine. She of course would have suffered; that is what patients on chemo do. But their suffering is worth it because they know it is lifesaving. Pamela is not the only American affected by a shortage of Taxol and other lifesaving drugs. Every day in hospitals across the country Americans already dealing with devastating illnesses must also face shortages of FDA-approved medications that could keep them alive. Today Taxol is still scarce.…
On the recordMay 23, 2012
Share & report
More from Harry Reid
Jan 27, 2021
The filibuster is going away. It is nothing that helps the country. It doesn’t help states. It doesn’t help individuals. It is on its way out. It’s a question of when it goes.
Dec 8, 2016
Mr. President, the history of Searchlight starts this way, the first paragraph of that book: Searchlight is like many Nevada towns and cities: it would never have come to be had gold not been discovered. Situated on rocky, windy, and arid…
Nov 29, 2016
Mr. President, reserving the right to object, the ranking member of the Intelligence Committee, Senator Feinstein, has had some trouble with this. I spoke to her last night. She said to go ahead and let this go. She is totally in agreement…





